Attana highlighted in Today in America with Terry Bradshaw
Catch Attana on Today with America! Segment airs on March 5th, nationally in North America on Fox Business Network (4:00 PM ET, 3:00 PM CT, 2:00 PM MT, 1:00 PM PT) and on March 11th on CNN Headline News (Comcast Cable, Seattle- Tacoma, 2:24 pm, 3:24 pm, 5:54 pm, 6:24 pm).
- (1888PressRelease) March 04, 2011 - Stockholm, Sweden - Attana AB, developer of biosensors, is proud to announce our participation in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to "Improving Diagnostic Outcomes through Biosensor Technology" as part of the show's "Medical Minutes" series.
The program aims to inform the general public about the complexities of the human body and to emphasize the challenges of the drug development process. Furthermore, the program presents a solution interesting for scientists and decision makers working within the field of drug development, showing how it is possible to save both time and money when developing drugs. Having access to biologically relevant information, i.e. experimental data that mimics the conditions of the human body as closely as possible is crucial for finding the best new drug candidate. The Attana Cell 200 biosensor has the unique ability to measure molecular interactions directly on human cells and provides critical data to the drug development process.
For every new drug on the market, thousands of candidate molecules have failed during the research and test phases. The later in the process a candidate fails, the more time and money is spent on it. When a candidate reaches the clinical phase with human test subjects, the costs increase significantly. Besides the fact that a faulty drug increases costs, it also has the potential to harm the test persons. Therefore, a drug that is thoroughly investigated before it enters clinical trials risks less harmful consequences.
Attana's technology provides biologically relevant information that enables selection of the good candidates and sorts out the unsuitable ones earlier in the drug development process. Biologically relevant information is crucial for the drug development process- it helps save both time and money and in finding the best new drug candidate.
For a preview of the show visit our web page at www.attana.com. If you want to find out more about Attana and our products, send an email to info ( @ ) attana dot com dot
The segment will be aired on March 5th, nationally in North America on Fox Business Network (4:00 PM ET, 3:00 PM CT, 2:00 PM MT, 1:00 PM PT) and on March 11th on CNN Headline News (Comcast Cable, Seattle- Tacoma, 2:24 pm, 3:24 pm, 5:54 pm, 6:24 pm). The Today in America program is an independent production hence not a Fox Business Network or CNN Headline News production.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam